ACADIA Pharmaceuticals (ACAD) Earnings Analysis
ACADIA Pharmaceuticals (ACAD) has no confirmed upcoming earnings date. In its last reported quarter (2026-02-25) ACAD beat analyst consensus (+1067.9% EPS surprise). Trailing P/E 11.19.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does ACAD next report earnings?
No confirmed upcoming earnings date is currently scheduled for ACAD. This page updates as the calendar is published.
ACAD last-quarter earnings result
| Last reported quarter | 2026-02-25 |
|---|---|
| Result vs consensus | Beat (+1067.9% EPS surprise) |
ACAD consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on ACAD
Frequently asked questions
When does ACAD next report earnings?
ACAD has no confirmed upcoming earnings date right now; this page updates as the calendar is published.
Did ACAD beat earnings last quarter?
In its 2026-02-25 report, ACAD beat analyst consensus (+1067.9% EPS surprise).
Where can I see ACAD analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for ACAD are in the SniperIQ app: https://app.sniperiq.ai/register